Physician profile
Douglas Gadowski
NPI 1013911460
$5,018.09
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,474 · 2020: $878 · 2021: $940 · 2022: $601 · 2023: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $124.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $863.72 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $758.47 | 2019-2023 | Farxiga |
| Amarin Pharma, INC. | $505.03 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $468.52 | 2019-2021 | |
| Pfizer INC. | $285.10 | 2019-2020 | |
| Abbvie INC. | $247.79 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $242.02 | 2021-2022 | |
| Glaxosmithkline, LLC. | $235.95 | 2021-2022 | |
| Amgen INC. | $221.86 | 2019-2021 | |
| Abbott Laboratories | $167.66 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $138.88 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 2019 | |
| Gilead Sciences, INC. | $124.99 | 2019 | |
| Lantheus Medical Imaging, INC. | $118.08 | 2019-2020 | |
| Cardiovascular Systems INC. | $116.52 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $105.72 | 2021 | |
| Esperion Therapeutics, INC. | $100.19 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $95.97 | 2019 | |
| Novartis Pharmaceuticals Corporation | $84.61 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $12.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Gadowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.